Aktienanalyse zu Cadre Holdings, Inc. (CDRE)CDRECadre Holdings, Inc.

Cadre Holdings, Inc. is engaged in the manufacturing and distribution of safety products. The Company's equipment provides protection to allow users to safely perform their duties and protect those around them in hazardous or life-threatening situations. Its core products include body armor, explosive ordnance disposal equipment, duty gear and nuclear safety products. Its principal body armor product offerings include concealable, corrections and tactical armor, which provide varying levels of protection against ballistic or sharp instrument threats. It offers an engineered portfolio of critical operator survival suits, blast sensors, accessories and vehicle blast attenuation seats for bomb safety technicians, among others. Its engineered products are utilized in over 100 countries by federal, state and local law enforcement, fire and rescue professionals, explosive ordnance disposal teams, and emergency medical technicians. Its key brands include Safariland and Med-Eng, among others. It operates in the Industrials sector (ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUP industry).

Cadre Holdings Inc is a good buy right now due to its recent positive performance and strong analyst ratings. The stock has seen a 7.45% increase over the last five days, and analysts have set a price target of $43, suggesting a potential upside of 63.1%. Additionally, the forward P/E ratio of 18.15 indicates that the stock may be undervalued compared to its growth prospects. However, the main risk is the recent insider selling by CEO Warren B. Kanders, who sold 75,000 shares, which could signal a lack of confidence in the company's near-term performance.